Adrien Buisson
Impact in
-
- PARP inhibition in cancer therapy
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Olivier Trédan (3 shared papers)Valeria Viassolo (3 shared papers)Sophie Giraud (3 shared papers)Valérie Bonadona (3 shared papers)Sana Intidhar Labidi‐Galy (3 shared papers)Alexandre Bodmer (2 shared papers)Isabelle Treilleux (4 shared papers)Alex Friedlaender (2 shared papers)
In The Last Decade
Adrien Buisson
15 papers receiving 162 citations
Peers
Comparison fields: 5 of 39
- Oncology 84
- Cancer Research 30
- Genetics 45
- Pathology and Forensic Medicine 20
- Pulmonary and Respiratory Medicine 31
Countries citing papers authored by Adrien Buisson
This map shows the geographic impact of Adrien Buisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Buisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Buisson more than expected).
Fields of papers citing papers by Adrien Buisson
This network shows the impact of papers produced by Adrien Buisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Buisson. The network helps show where Adrien Buisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrien Buisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 76 | |
| 2 | 2021 | 18 | |
| 3 | 2019 | 15 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 7 | |
| 7 | 2019 | 7 | |
| 8 | 2020 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2021 | 2 | |
| 12 | 2019 | 2 | |
| 13 | 2018 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2023 | 0 | |
| 17 | 2022 | 0 |
About Adrien Buisson
Adrien Buisson is a scholar working on Oncology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 163 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (7 papers), PARP inhibition in cancer therapy (6 papers), Ovarian cancer diagnosis and treatment (3 papers), Genetic factors in colorectal cancer (3 papers), DNA Repair Mechanisms (2 papers), Cancer Genomics and Diagnostics (2 papers), Cutaneous Melanoma Detection and Management (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Oncology (84 citations), Cancer Research (30 citations), Genetics (45 citations), Pathology and Forensic Medicine (20 citations) and Pulmonary and Respiratory Medicine (31 citations). Adrien Buisson has collaborated with scholars based in France, Belgium and Spain. Frequent co-authors include Olivier Trédan, Valeria Viassolo, Sophie Giraud, Valérie Bonadona, Sana Intidhar Labidi‐Galy, Alexandre Bodmer, Isabelle Treilleux, Alex Friedlaender, Julien Péron and Pierre O. Chappuis. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Human Genetics, Journal for ImmunoTherapy of Cancer, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.